Barclays PLC Selecta Biosciences Inc Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$0.62 - $0.85 $50,355 - $69,035
-81,218 Reduced 40.57%
118,953 $78,000
Q4 2023

Feb 15, 2024
BUY
$0.67 - $1.35 $94,139 - $189,683
140,506 Added 235.49%
200,171 $138,000
Q3 2023

Nov 07, 2023
SELL
$1.02 - $1.23 $1,606 - $1,937
-1,575 Reduced 2.57%
59,665 $63,000
Q2 2023

Aug 03, 2023
BUY
$1.04 - $1.4 $24,169 - $32,535
23,240 Added 61.16%
61,240 $69,000
Q4 2022

Feb 13, 2023
SELL
$0.96 - $1.6 $1,111 - $1,852
-1,158 Reduced 2.96%
38,000 $43,000
Q3 2022

Nov 03, 2022
SELL
$1.33 - $2.6 $3,138 - $6,136
-2,360 Reduced 5.68%
39,158 $64,000
Q2 2022

Aug 12, 2022
SELL
$0.67 - $1.4 $10,311 - $21,547
-15,391 Reduced 27.04%
41,518 $54,000
Q1 2022

May 16, 2022
SELL
$1.23 - $3.31 $67,428 - $181,454
-54,820 Reduced 49.07%
56,909 $70,000
Q4 2021

Feb 14, 2022
BUY
$2.89 - $4.43 $215,643 - $330,553
74,617 Added 201.06%
111,729 $365,000
Q3 2021

Nov 09, 2021
BUY
$3.36 - $4.62 $26,990 - $37,112
8,033 Added 27.62%
37,112 $155,000
Q2 2021

Aug 13, 2021
SELL
$2.82 - $5.01 $110,366 - $196,076
-39,137 Reduced 57.37%
29,079 $121,000
Q1 2021

May 13, 2021
BUY
$2.92 - $5.07 $26,907 - $46,720
9,215 Added 15.62%
68,216 $309,000
Q4 2020

Feb 11, 2021
SELL
$1.64 - $3.42 $28,581 - $59,603
-17,428 Reduced 22.8%
59,001 $178,000
Q3 2020

Nov 12, 2020
BUY
$2.18 - $2.84 $4,549 - $5,927
2,087 Added 2.81%
76,429 $190,000
Q2 2020

Aug 12, 2020
BUY
$1.83 - $4.06 $68,136 - $151,165
37,233 Added 100.33%
74,342 $210,000
Q1 2020

May 13, 2020
BUY
$1.5 - $4.52 $55,662 - $167,728
37,108 Added 3710800.0%
37,109 $89,000
Q4 2019

Feb 10, 2020
BUY
$1.32 - $2.47 $1 - $2
1 New
1 $0
Q3 2019

Nov 14, 2019
SELL
$1.6 - $2.08 $4,192 - $5,449
-2,620 Closed
0 $0
Q2 2019

Aug 14, 2019
SELL
$1.79 - $3.05 $12,617 - $21,499
-7,049 Reduced 72.9%
2,620 $4,000
Q1 2019

May 15, 2019
SELL
$1.47 - $3.06 $4,398 - $9,155
-2,992 Reduced 23.63%
9,669 $23,000
Q4 2018

Feb 14, 2019
BUY
$2.66 - $15.93 $15,723 - $94,162
5,911 Added 87.57%
12,661 $34,000
Q3 2018

Nov 14, 2018
BUY
$12.07 - $16.0 $65,588 - $86,944
5,434 Added 412.92%
6,750 $105,000
Q2 2018

Aug 14, 2018
SELL
$9.36 - $13.25 $15,050 - $21,306
-1,608 Reduced 54.99%
1,316 $17,000
Q1 2018

May 15, 2018
SELL
$8.49 - $11.82 $908 - $1,264
-107 Reduced 3.53%
2,924 $30,000
Q4 2017

Feb 14, 2018
BUY
$8.97 - $23.38 $12,145 - $31,656
1,354 Added 80.74%
3,031 $30,000
Q3 2017

Nov 14, 2017
BUY
$15.22 - $20.03 $25,523 - $33,590
1,677
1,677 $31,000

Others Institutions Holding SELB

# of Institutions
5
Shares Held
4.67M
Call Options Held
0
Put Options Held
0
View Full List

About SELECTA BIOSCIENCES INC

SELB Quotes by TradingView
  • Ticker SELB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 152,712,992
  • Market Cap $128M
  • Description
  • Selecta Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. The company's lead therapeutic gene therapy program is SEL-302 that is in preclinical stage to improve the treatment of methylmalonic acidemia. I...
More about SELB
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email